Arab Region | Proportion of the target population with access to pneumococcal conjugate third dose PCV3 (Arab countries, 2008–2021)
Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the recommended doses of pneumococcal conjugate vaccine.
Publisher
Arab Development Portal
Origin
Arab Region
Records
165
Source
Arab Region | Proportion of the target population with access to pneumococcal conjugate third dose PCV3 (Arab countries, 2008–2021)
| Year |
value
Min
Max
|
Location |
|---|---|---|
| 2018 | 91 | Algeria |
| 2021 | 91 | Algeria |
| 2013 | 82 | Djibouti |
| 2014 | 78 | Djibouti |
| 2016 | 68 | Djibouti |
| 2018 | 84 | Djibouti |
| 2019 | 85 | Djibouti |
| 2020 | 70 | Djibouti |
| 2010 | 99 | Bahrain |
| 2011 | 99 | Bahrain |
| 2013 | 99 | Bahrain |
| 2016 | 99 | Bahrain |
| 2017 | 97 | Bahrain |
| 2018 | 98 | Bahrain |
| 2019 | 97 | Bahrain |
| 2020 | 99 | Bahrain |
| 2021 | 99 | Bahrain |
| 2017 | 33 | Iraq |
| 2018 | 33 | Iraq |
| 2020 | 0 | Iraq |
| 2021 | 0 | Iraq |
| 2008 | 99 | Kuwait |
| 2013 | 99 | Kuwait |
| 2015 | 99 | Kuwait |
| 2016 | 99 | Kuwait |
| 2017 | 82 | Lebanon |
| 2019 | 82 | Lebanon |
| 2020 | 74 | Lebanon |
| 2021 | 70 | Lebanon |
| 2014 | 39 | Libya |
| 2015 | 71 | Libya |
| 2016 | 96 | Libya |
| 2017 | 94 | Libya |
| 2018 | 72 | Libya |
| 2019 | 73 | Libya |
| 2020 | 73 | Libya |
| 2021 | 73 | Libya |
| 2015 | 71 | Mauritania |
| 2016 | 71 | Mauritania |
| 2017 | 72 | Mauritania |
| 2018 | 72 | Mauritania |
| 2019 | 76 | Mauritania |
| 2021 | 65 | Mauritania |
| 2013 | 80 | Morocco |
| 2015 | 95 | Morocco |
| 2016 | 98 | Morocco |
| 2017 | 99 | Morocco |
| 2018 | 99 | Morocco |
| 2019 | 98 | Morocco |
| 2021 | 98 | Morocco |
| 2010 | 99 | Oman |
| 2011 | 99 | Oman |
| 2013 | 99 | Oman |
| 2018 | 99 | Oman |
| 2019 | 99 | Oman |
| 2020 | 99 | Oman |
| 2021 | 99 | Oman |
| 2009 | 99 | Qatar |
| 2010 | 97 | Qatar |
| 2011 | 98 | Qatar |
| 2012 | 92 | Qatar |
| 2013 | 99 | Qatar |
| 2014 | 94 | Qatar |
| 2015 | 95 | Qatar |
| 2017 | 98 | Qatar |
| 2018 | 98 | Qatar |
| 2019 | 98 | Qatar |
| 2020 | 98 | Qatar |
| 2009 | 98 | Saudi Arabia |
| 2010 | 98 | Saudi Arabia |
| 2011 | 98 | Saudi Arabia |
| 2013 | 98 | Saudi Arabia |
| 2015 | 98 | Saudi Arabia |
| 2016 | 98 | Saudi Arabia |
| 2018 | 98 | Saudi Arabia |
| 2020 | 95 | Saudi Arabia |
| 2013 | 30 | Sudan |
| 2014 | 97 | Sudan |
| 2015 | 93 | Sudan |
| 2016 | 93 | Sudan |
| 2018 | 93 | Sudan |
| 2019 | 93 | Sudan |
| 2011 | 95 | United Arab Emirates |
| 2012 | 96 | United Arab Emirates |
| 2013 | 98 | United Arab Emirates |
| 2015 | 99 | United Arab Emirates |
| 2016 | 99 | United Arab Emirates |
| 2019 | 99 | United Arab Emirates |
| 2020 | 84 | United Arab Emirates |
| 2021 | 95 | United Arab Emirates |
| 2012 | 67 | Yemen |
| 2013 | 73 | Yemen |
| 2015 | 69 | Yemen |
| 2016 | 71 | Yemen |
| 2019 | 72 | Yemen |
| 2012 | 25 | Palestine |
| 2013 | 97 | Palestine |
| 2014 | 99 | Palestine |
| 2019 | 99 | Palestine |
| 2021 | 96 | Tunisia |
Arab Region | Proportion of the target population with access to pneumococcal conjugate third dose PCV3 (Arab countries, 2008–2021)
Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the recommended doses of pneumococcal conjugate vaccine.
Publisher
Arab Development Portal
Origin
Arab Region
Records
165
Source